Dose-escalation study of the pharmacokinetics and pharmacodynamics of rivaroxaban in healthy elderly subjects

By Kubitza Dagmar   Becka Michael   Roth Angelika   Mueck Wolfgang  

Current Medical Research and Opinion, Vol. 24, Iss. 10, 2008-10 ,pp. : 2757-2765

Informa Healthcare

Access to resources Recommend Favorite

Switching from risperidone to olanzapine in a one-year, randomized, open-label effectiveness study of schizophrenia

By Faries Douglas E.   Ascher-Svanum Haya   Nyhuis Allen W.   Kinon Bruce J.  

Current Medical Research and Opinion, Vol. 24, Iss. 5, 2008-05 ,pp. : 1399-1405

Informa Healthcare

Access to resources Recommend Favorite

Acid‐inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects ‐ a randomised open‐label cross‐over study

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 6, 2015-09 ,pp. : 719-730

John Wiley & Sons Inc

Access to resources Recommend Favorite

Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal–bolus regimens: insights from the PREDICTIVE study

By Hermansen Kjeld   Dornhorst Anne   Sreenan Seamus  

Current Medical Research and Opinion, Vol. 25, Iss. 11, 2009-11 ,pp. : 2601-2608

Informa Healthcare

Access to resources Recommend Favorite

Contribution of rivaroxaban to the international normalized ratio when switching to warfarin for anticoagulation as determined by simulation studies

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 79, Iss. 6, 2015-06 ,pp. : 959-966

John Wiley & Sons Inc

Access to resources Recommend Favorite